معرفی
Christopher Buckley is the Kennedy Professor of Translational Rheumatology and Director of Clinical Research at the Kennedy Institute of Rheumatology, University of Oxford. He holds concurrent roles as Director of NIHR Infrastructure for Birmingham Health Partners. His research focuses on fibroblast biology in rheumatoid arthritis (RA), stromal cell interactions, and translational medicine approaches to stratified therapy. He leads the Arthritis Therapy Acceleration Programme (A-TAP), advancing precision medicine strategies for immune-mediated inflammatory diseases.
Educations:
- BSc Biochemistry, University of Oxford (1985)
- MBBS Medicine, Royal Free Hospital, London (1990)
- DPhil in Molecular Medicine (Wellcome Trust Fellowship) under Prof. John Bell (Oxford)
Research Interests:
- Pathogenic fibroblast subpopulations in RA and systemic sclerosis
- Tissue-resident memory T cells in chronic inflammation
- Spatial transcriptomics of synovial and tendon tissues
- Pro-resolving fibroblast networks during inflammation resolution
- Development of biomarkers for disease flare/remission
Awards & Leadership:
- MRC Senior Clinical Fellowship (2001)
- Arthritis Research UK Professorship (2002)
- Director, Birmingham NIHR Clinical Research Facility (2012-2017)
Key Projects:
- Leading A-TAP's stratified pathology approach for drug development
- Investigating Wnt signaling in stromal inflammation
- Developing cellular atlases of joints using spatial transcriptomics
۰مقاله ثبتشده
